Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Other financing activities (2021 - 2026)

bioAffinity Technologies has reported Other financing activities over the past 5 years, most recently at $14340.0 for Q1 2026.

  • Quarterly Other financing activities fell 95.61% to $14340.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $35022.0 through Mar 2026, down 97.32% year-over-year, with the annual reading at $347298.0 for FY2025, 72.48% down from the prior year.
  • Other financing activities was $14340.0 for Q1 2026 at bioAffinity Technologies, up from -$258057.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $506304.0 in Q4 2024 and troughed at -$258057.0 in Q4 2025.
  • The 5-year median for Other financing activities is $170255.0 (2023), against an average of $142824.1.
  • Year-over-year, Other financing activities soared 538.02% in 2023 and then crashed 150.97% in 2025.
  • A 5-year view of Other financing activities shows it stood at -$156094.0 in 2022, then skyrocketed by 250.24% to $234510.0 in 2023, then soared by 115.9% to $506304.0 in 2024, then crashed by 150.97% to -$258057.0 in 2025, then soared by 105.56% to $14340.0 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Other financing activities are $14340.0 (Q1 2026), -$258057.0 (Q4 2025), and $67132.0 (Q3 2025).